We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

OPEN:NASDAQOpendoor Technologies Inc Analysis

Data as of 2026-08-26 - not real-time

$3.60

Latest Price

9/10Risk

Risk Level: High

Executive Summary

The moving-average structure behind Opendoor Technologies Inc. is bearish at $3.60, with short-term averages lagging the long-term ones. It has lost 20.9% over the past 30 days. RSI sits at 45.3, which reads as neutral, and MACD momentum is bullish. Price has been bracketed by support at $3.21 and resistance at $4.22.
The company is not currently profitable on a trailing basis, so earnings multiples offer no valuation support. Consensus targets land 30.6% above where the shares trade now. Revenue is contracting at 43.7% on a -46.7% profit margin.
Risk scores 9 out of 10, which is high for this asset class. With 30-day volatility of 73.6%, a beta of 3.18 and a maximum drawdown of 68.1%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 93 on the fear-greed composite.
The horizons line up on sell — conviction 4 out of 10.

Top Market Events

Yahoo Finance21dOpendoor Technologies Inc OPEN Q2 2026 Earnings Call Highlights: Record Acquisition Growth .Technology real estate company Opendoor NASDAQ:OPEN in Q2 CY2026, with sales falling 43.$650 million of 0% coupon convertible notes, concurrent $158 million share repurchase, and capped call transactions,...

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 4/10

Key Factors

  • Short-term moving averages stacked below long-term ones
  • Trading below the 200-day average of 5.25
  • MACD momentum is positive

Medium Term

1–3 years
Cautious
Model confidence: 4/10

Key Factors

  • Short-term moving averages stacked below long-term ones
  • Trading below the 200-day average of 5.25
  • Analyst targets imply +30.6% versus the current price

Long Term

> 3 years
Cautious
Model confidence: 4/10

Key Factors

  • Negative profit margin of -46.7%
  • Analyst targets imply +30.6% versus the current price
  • Negative return on equity of -196.9%

Key Metrics & Analysis

Financial Health

Revenue Growth-43.70%
Profit Margin-46.74%
P/E Ratio-76.2
ROE-196.89%
ROA-10.91%
Debt/Equity214.88
P/B Ratio3.8
Op. Cash Flow$-459000000
Free Cash Flow$48.8M
Industry P/E32.9

Technical Analysis

TrendBearish
RSI45.3
Support$3.21
Resistance$4.22
MA 20$3.62
MA 50$4.15
MA 200$5.25
MACDBullish
VolumeIncreasing
Fear & Greed Index93.41

Valuation

Target Price$4.70
Upside/Downside30.56%
GradeFair
TypeBlend

Risk Assessment

Beta3.18
Volatility73.60%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.